Skip to ContentSkip to Navigation
Practical matters How to find us prof. dr. J.H.M. (Anke) van den Berg

Research interests

I am a clinical molecular biologist at the UMCG and a principal investigator in the Stem cells, Ageing, Leukemia and Lymphoma (SALL) program of the Cancer Research Center Groningen. My main research interest is studying the molecular pathogenesis of B cell Hodgkin and non-Hodgkin lymphoma. The specific fields of interest are focused around genomic aberrations, genetic susceptibility, the role of small and long noncoding RNAs and  the cross-talk between tumor cells and the micro environment.


Disturbed antigen presentation in classical Hodgkin Lymphoma; implications for immune checkpoint inhibitor therapy

ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma

Long noncoding RNAs as a novel component of the Myc transcriptional network

miR-24-3p Is Overexpressed in Hodgkin Lymphoma and Protects Hodgkin and Reed-Sternberg Cells from Apoptosis

Long Noncoding RNA Expression Profiling in Normal B-Cell Subsets and Hodgkin Lymphoma Reveals Hodgkin and Reed-Sternberg Cell Specific Long Noncoding RNAs

Mutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumors

Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC

Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma

WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage

Primary and acquired resistance mechanisms to immune checkpoint inhibition in Hodgkin lymphoma

Read more